April 27, 2024
Crystal inks US$125m tech export deal
[DISCLOSURE] Crystal Genomics (083790) announced on June 14 that it has signed an exclusive global option and license contract worth US$125 million with Canada’s Aptose Biosciences for the development of CG026806 in China.
By Hwang You-mee (glamazon@heraldcorp.com)
EDITOR'S PICKS
-
Korea’s top finance firms put aside W1.7tr for Hong Kong-tied ELS compensation
-
Samsung mobile chief, Google device head meet in Seoul
-
Posco Future M, Honda to launch battery materials venture in Canada
-
Hybe-Ador feud should have limited effect on Hybe's overall performance: analysts
-
Experts raise concerns about Japan putting pressure on Naver over Line
-
SK hynix profits soar on AI chip boom
-
Korea enters clear growth path as Q1 growth hits 2-year high
-
Hyundai, Kia seek to boost presence in China market
